SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-010062
Filing Date
2024-03-08
Accepted
2024-03-08 17:54:54
Documents
1
Period of Report
2024-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709938483.html 4  
1 FORM 4 wk-form4_1709938483.xml 4 3891
  Complete submission text file 0001628280-24-010062.txt   5687
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ARROWHEAD RESEARCH CORPORATION 201 SOUTH LAKE AVENUE, SUITE 703 PASADENA CA 91101
Business Address
Myszkowski Kenneth Allen (Reporting) CIK: 0001486672 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 24735944